We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rockwell Medical Inc | NASDAQ:RMTI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 0.28% | 1.815 | 0.41 | 8.48 | 1.83 | 1.73 | 1.82 | 383,691 | 05:00:07 |
|
Delaware
|
| |
38-3317208
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(I.R.S. Employer
Identification No.) |
|
|
Ryan A. Murr
Gibson, Dunn & Crutcher LLP 555 Mission Street, Suite 3000 San Francisco, CA 94105 (415) 393-8373 |
| |
Megan C. Timmins
SVP, General Counsel and Secretary Rockwell Medical, Inc. 30142 S. Wixom Road Wixom, Michigan 48393 (248) 960-9009 |
|
|
Large Accelerated Filer
☐
|
| |
Accelerated Filer
☐
|
|
|
Non-Accelerated Filer
☒
|
| |
Smaller Reporting Company
☒
|
|
| | | |
Emerging Growth Company
☐
|
|
| | |
Page
|
| |||
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 12 | | | |
| | | | 12 | | | |
| | | | 13 | | | |
| | | | 14 | | |
Item
|
| |
Amount
|
| |||
SEC registration fee
|
| | | $ | 170 | | |
Legal fees and expenses
|
| | | | 10,000 | | |
Accounting fees and expenses
|
| | | | 20,000 | | |
Printing and miscellaneous expenses
|
| | | | 10,000 | | |
Total
|
| | | $ | 40,170 | | |
Exhibit
Number |
| |
Description
|
|
3.1 | | | | |
3.2 | | | | |
3.3 | | | | |
3.4 | | | | |
5.1* | | | | |
10.1 | | | Securities Purchase Agreement, dated April 6, 2022, by and between the Company and DaVita, Inc. (incorporated by reference to the Company’s Form 10-Q for the quarter ended March 31, 2022 filed May 16, 2022). | |
23.1* | | | | |
23.2* | | | | |
24.1* | | | | |
107*
|
| | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Mark Strobeck, Ph.D.
Mark Strobeck, Ph.D.
|
| |
President, Chief Executive Officer and Director
(Principal Executive Officer) |
| |
July 14, 2022
|
|
|
/s/ Russell Skibsted
Russell Skibsted
|
| |
Chief Financial Officer
(Principal Financial Officer) |
| |
July 14, 2022
|
|
|
/s/ Paul E. McGarry
Paul E. McGarry
|
| | Principal Accounting Officer | | |
July 14, 2022
|
|
|
/s/ John G. Cooper
John G. Cooper
|
| | Director | | |
July 14, 2022
|
|
|
/s/ Robert S. Radie
Robert S. Radie
|
| | Director | | |
July 14, 2022
|
|
|
/s/ Allen Nissenson
Allen Nissenson
|
| | Director | | |
July 14, 2022
|
|
|
/s/ Andrea Heslin Smiley
Andrea Heslin Smiley
|
| | Director | | |
July 14, 2022
|
|
|
/s/ Mark H. Ravich
Mark H. Ravich
|
| | Director | | |
July 14, 2022
|
|
1 Year Rockwell Medical Chart |
1 Month Rockwell Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions